Covishield Vaccine
CompositionChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) (NA)
RxPrescription Required
Packvial of 5 ml Solution for Injection
StorageStore in a refrigerator (2 - 8°C). Do not freeze.
Chemical ClassVaccines
Habit FormingNo
ManufacturerSerum Institute Of India Ltd
Covishield Vaccine has been developed by AstraZeneca with Oxford university in the UK and is being manufactured by the Serum Institute of India (SII) in Pune. Successful clinical trials have been conducted in S.Africa, Brazil, and the UK with bridging study results in the Indian population based on which the approval was granted by DCGI (Drugs Controller General of India)




